Across TCGA pan-cancer cohorts, RNU6-55P Mutation is linked to patient survival in 1 of 34 cancer types, making it a survival-associated RNU6-55P data layer compared with 5 for mass-spec protein.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher RNU6-55P Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6-55P expression acts as an unfavorable survival marker.

UCEC are the cancer types where RNU6-55P Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	OS	Median	IV	0.231	0.592	.036	6	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

Exploration

Same gene, other analysis: RNU6-55P tumor-vs-normal RNA expression · all RNU6-55P data types